board  (Seca)

Journal: Data in Brief

Article Title: Physiological responses to emotional video stimuli: ECG, EDA, and temperature data

doi: 10.1016/j.dib.2026.112720

Figure Lengend Snippet: BITalino (r)evolution biosignal acquisition board.

Article Snippet: Data collection , Data collection was performed using BITalino (r)evolution boards (PLUX Wireless Biosignals, S.A.), which recorded ECG, EDA, skin temperature, and accelerometer signals. Participants wore the NK-G04E-VR Virtual Reality Glasses during the experiment to view 18 emotionally evocative videos designed to elicit a range of emotions. Data were captured at a 1000 Hz sampling rate and stored with timestamps. Demographic data (age, gender, health conditions) were also collected. Participants were healthy adults, and those with neurological disorders were excluded. No data normalization was applied..

Techniques:

Journal: Data in Brief

Article Title: Physiological responses to emotional video stimuli: ECG, EDA, and temperature data

doi: 10.1016/j.dib.2026.112720

Figure Lengend Snippet: Mobile application (BitalinoScientiSST) interface used during data acquisition. (a) The main acquisition screen is used to start and stop recording after the participant ID is entered. (b) The Bluetooth device discovery and pairing screen is used to connect the BITalino device. (c) New-segment action used immediately before each video stimulus to split the session into stimulus-aligned recordings. (d) Example of the acquisition screen after creating a new segment for the next stimulus. Pressing New creates a new output file bitalino_n.txt ( n = 1 to 18), with one file per video clip, matching the file organisation described in the Data Description section.

Article Snippet: Data collection , Data collection was performed using BITalino (r)evolution boards (PLUX Wireless Biosignals, S.A.), which recorded ECG, EDA, skin temperature, and accelerometer signals. Participants wore the NK-G04E-VR Virtual Reality Glasses during the experiment to view 18 emotionally evocative videos designed to elicit a range of emotions. Data were captured at a 1000 Hz sampling rate and stored with timestamps. Demographic data (age, gender, health conditions) were also collected. Participants were healthy adults, and those with neurological disorders were excluded. No data normalization was applied..

Techniques:

Journal: bioRxiv

Article Title: Motor sequence analysis as a sensitive biomarker of dopaminergic degeneration in a non-human primate model of parkinsonism

doi: 10.64898/2026.04.23.720333

Figure Lengend Snippet: Experimental timeline for the hemiparkinsonism induction model in Sapajus apella . Baseline motor assessments (Staircase, Tube, and Brinkman board tests) were conducted during the pre-surgical period (approximately 2 weeks before surgery; not drawn to scale). At week 0 (W0), animals underwent MRI-guided stereotaxic surgery for unilateral 6-OHDA injection (2 µL at four equidistant SN sites; dissolved in 0.01% ascorbic acid saline) or vehicle-only injection (SHAM). Post-surgical motor assessment began at week 2 (W2). Animals were euthanized at week 4 (W4) for TH immunohistochemistry and optical fractionator stereology. Subjects: HP-4 (6-OHDA 4 mg/mL), HP-10 (6-OHDA 10 mg/mL), HP-40 (6-OHDA 40 mg/mL), SHAM (vehicle).

Article Snippet: These include: raw and session-level Brinkman board performance metrics (brinkman_session_metrics.xlsx), deviation variance summary statistics for the Brinkman board sequence analysis (brinkman_deviation_variance_summary.csv), Wilcoxon test results for Brinkman board sequence variability comparisons (brinkman_variability_wilcoxon_summary.xlsx), Brinkman board retrieval sequence matrices used to generate heatmap visualizations (brinkman_heatmap_matrices.xlsx), Wilcoxon test results for Staircase test parameters (staircase_wilcoxon_results.csv), and Wilcoxon test results for Tube test parameters (tube_wilcoxon_summary.csv).

Techniques: Injection, Saline, Immunohistochemistry

Journal: bioRxiv

Article Title: Motor sequence analysis as a sensitive biomarker of dopaminergic degeneration in a non-human primate model of parkinsonism

doi: 10.64898/2026.04.23.720333

Figure Lengend Snippet: Brinkman board: motor sequence analysis. (A) Left: schematic of the 50-slot Brinkman board (22 × 12 cm acrylic board; 25 vertically and 25 horizontally oriented wells). Right: session-level deviation variance (mean ± SEM) before (blue) and after (orange) surgical intervention. Deviation variance quantifies within-session deviations between actual and expected retrieval order (see Methods 2.7); higher values indicate greater sequence disorganization. P-values from Mann-Whitney U tests (pre vs. post) are shown below each subject label. (B) Retrieval sequence heatmaps for the dominant hand across pre- (left) and post-lesion (right) sessions. Each row represents one session; each column represents an ordinal retrieval step (1–50). Color encodes the pellet number retrieved at each step (color scale: blue = low pellet number, red = high pellet number; range 10–50). The white dashed diagonal represents the ideal sequential strategy, where pellet number equals retrieval order. Organized performance appears as a smooth blue-to-red diagonal gradient; disorganization manifests as color fragmentation across the heatmap. N = 25 sessions per phase. Note: BEG HP10 showed high baseline sequence variability in both phases; white cells in AOR HP40 post-lesion indicate excluded sessions.

Article Snippet: These include: raw and session-level Brinkman board performance metrics (brinkman_session_metrics.xlsx), deviation variance summary statistics for the Brinkman board sequence analysis (brinkman_deviation_variance_summary.csv), Wilcoxon test results for Brinkman board sequence variability comparisons (brinkman_variability_wilcoxon_summary.xlsx), Brinkman board retrieval sequence matrices used to generate heatmap visualizations (brinkman_heatmap_matrices.xlsx), Wilcoxon test results for Staircase test parameters (staircase_wilcoxon_results.csv), and Wilcoxon test results for Tube test parameters (tube_wilcoxon_summary.csv).

Techniques: Sequencing, MANN-WHITNEY

Journal: bioRxiv

Article Title: Motor sequence analysis as a sensitive biomarker of dopaminergic degeneration in a non-human primate model of parkinsonism

doi: 10.64898/2026.04.23.720333

Figure Lengend Snippet: Exploratory association between behavioral impairment and nigrostriatal degeneration. Scatter plots (panels A–C) show the linear regression between SN tyrosine hydroxylase (TH)-positive cell loss (x-axis; %) and baseline-normalized change in behavioral metrics (y-axis; %), individually for each subject. Regression lines (red dashed), 95% confidence intervals (pink shading), R² values, and p-values are displayed within each panel. Given the small sample size (n = 4), analyses are strictly exploratory; effect sizes and directional consistency rather than statistical significance are the primary interpretive focus. (A) Staircase Impairment: baseline-normalized change in reward retrieval success rate on the dominant side (R² = 0.48, p = 0.307). A moderate, non-significant negative trend suggests that greater TH loss is associated with greater staircase impairment, although the relationship is not linear across the concentration range tested. (B) Tube Asymmetry: baseline-normalized change in forelimb use asymmetry between the dominant and non-dominant sides (R² = 0.01, p = 0.889). No meaningful linear association was observed between TH loss and tube asymmetry, consistent with the interpretation that forelimb asymmetry reflects individual compensatory strategies rather than degeneration severity per se. (C) Strategy Chaoticity (Brinkman board deviation variability): baseline-normalized change in session-level deviation variance (R² = 0.18, p = 0.571). The absence of a clear linear relationship is consistent with the heterogeneous nature of motor sequence reorganization across subjects, particularly given BEG HP10’s high pre-lesion baseline variability. (D) Animal-level integrated summary heatmap. Each row represents one subject (AMBEN = BEN HP4; AMBEG = BEG HP10; AOR = AOR HP40; AMAQX = SHAM); each column represents one metric: SN TH Loss (%), Staircase Impairment (baseline-normalized change %), Tube Asymmetry (baseline-normalized change %), and Strategy Chaoticity/Variability (baseline-normalized change %). Color scale reflects the magnitude of each value (darker red = higher absolute value; lighter yellow = values near zero or negative change). Numerical values are displayed within cells. Negative values in behavioral metrics indicate maintained or improved performance relative to baseline, potentially reflecting motor learning, task adaptation, or compensatory dopaminergic upregulation. The heatmap is intended as a qualitative, multidimensional overview to support hypothesis generation rather than statistical inference.

Article Snippet: These include: raw and session-level Brinkman board performance metrics (brinkman_session_metrics.xlsx), deviation variance summary statistics for the Brinkman board sequence analysis (brinkman_deviation_variance_summary.csv), Wilcoxon test results for Brinkman board sequence variability comparisons (brinkman_variability_wilcoxon_summary.xlsx), Brinkman board retrieval sequence matrices used to generate heatmap visualizations (brinkman_heatmap_matrices.xlsx), Wilcoxon test results for Staircase test parameters (staircase_wilcoxon_results.csv), and Wilcoxon test results for Tube test parameters (tube_wilcoxon_summary.csv).

Techniques: Concentration Assay, Sequencing